Diabetic Macular Edema (DME) Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01787669Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaTreatment
NCT02348918Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular EdemaTreatment
NCT01610557Ranibizumab and Bevacizumab for Diabetic Macular EdemaTreatment
NCT00874744Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular EdemaTreatment
NCT02663141Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular EdemaTreatment